암 영상 진단 시스템 시장 : 영상 진단법별, 용도별, 최종사용자별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율, 예측(2025-2032년)

Cancer Imaging System Market size was valued at US$ 21,987.24 Million in 2024, expanding at a CAGR of 9.5% from 2025 to 2032.

The Cancer Imaging System market refers to the global industry focused on technologies and equipment used to detect, diagnose, and monitor cancer through medical imaging. These systems include modalities such as MRI (Magnetic Resonance Imaging), CT (Computed Tomography), PET (Positron Emission Tomography), ultrasound, and mammography. Cancer imaging plays a vital role in early detection, staging, treatment planning, and evaluating the effectiveness of therapies. Increasing global cancer prevalence, rising awareness about early diagnosis, and advancements in imaging technologies are key drivers of this market.

Innovations like AI-enhanced image interpretation, hybrid imaging systems, and molecular imaging are improving accuracy and diagnostic capabilities. Governments and health organizations worldwide are investing in cancer screening programs, further fueling demand. Moreover, the growing aging population and lifestyle-related cancer risks contribute to market expansion. However, high equipment costs and limited access in low-income regions remain challenges. Overall, the market is evolving rapidly to support precision oncology and patient-centred care.

Cancer Imaging System Market- Market Dynamics

Radiomics enables personalized cancer imaging by extracting data-driven tumor insights.

A niche driver in the Cancer Imaging System market is the growing use of radiomics for personalized oncology. Radiomics involves extracting large volumes of quantitative data from medical images using advanced algorithms. These data points can reveal tumor characteristics such as shape, texture, and intensity that are not visible to the naked eye. This information helps in assessing tumor heterogeneity, predicting treatment response, and improving prognostic accuracy. As precision medicine advances, radiomics is becoming crucial for tailoring cancer treatment to individual patients.

It offers a non-invasive way to gather tumor biology insights, reducing the need for repeated biopsies. Integration with artificial intelligence enhances its ability to detect patterns and correlations. Radiomics also supports clinical decision-making and speeds up research in cancer therapeutics. Its application is expanding in imaging modalities like CT, MRI, and PET. The increasing focus on data-driven healthcare further strengthens its role. As adoption grows, radiomics is set to significantly impact cancer imaging strategies.

Cancer Imaging System Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.5% over the forecast period (2025-2032)

Based on Imaging Modality segmentation, Magnetic Resonance Imaging (MRI) was predicted to show maximum market share in the year 2024

Based on application segmentation, Breast Cancer was the leading application in 2024

Based on region, North America was the leading revenue generator in 2024

Cancer Imaging System Market- Segmentation Analysis:

The Global Cancer Imaging System Market is segmented on the basis of Imaging Modality, Application, End-user, and Region.

The market is divided into three categories based on Imaging Modality: Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography (PET), Ultrasound, Mammography, and Others. Magnetic Resonance Imaging (MRI) is the most dominant segment in the Cancer Imaging System market due to its superior soft tissue contrast and ability to provide detailed images without ionizing radiation. MRI is widely used for detecting and staging various cancers, including brain, breast, prostate, and liver cancers.

Its advanced functional imaging techniques, such as diffusion-weighted imaging and spectroscopy, enable better tumor characterization and treatment monitoring. Growing demand for non-invasive and precise diagnostic tools, along with continuous technological advancements, further strengthens MRI's leading position in this market.

The market is divided into two categories based on application: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, and Others. Breast Cancer is the most dominant segment in the Cancer Imaging System market due to its high prevalence and the critical need for early detection and screening. Mammography and MRI are widely used for breast cancer imaging, enabling accurate diagnosis and monitoring.

Government screening programs and growing awareness about breast cancer contribute to increased demand for imaging systems. Additionally, advancements in imaging technology have improved the detection of small tumors, enhancing treatment outcomes. This strong focus on breast cancer drives significant market growth within this segment.

Cancer Imaging System Market- Geographical Insights

North America holds a dominant position in the Cancer Imaging System market, driven by high cancer prevalence, advanced healthcare infrastructure, and strong investment in medical technology. The U.S. leads the region with widespread adoption of advanced imaging modalities and integration of AI in diagnostics. Supportive government initiatives and increasing demand for early detection further boost growth. Canada also contributes to rising cancer screening programs and growing access to modern imaging equipment.

The United States represents the largest market for cancer imaging systems globally, supported by a high incidence of cancer and a well-established healthcare system. The country sees significant investments in diagnostic technologies, with widespread use of MRI, CT, PET, and hybrid imaging for early cancer detection and treatment monitoring. Government initiatives like the Cancer Moonshot and expanded Medicare coverage for screening procedures enhance accessibility to imaging services.

Cancer Imaging System Market- Competitive Landscape:

The competitive landscape of the Cancer Imaging System market is characterized by the presence of several global and regional players offering a wide range of imaging solutions. Industry leaders like GE HealthCare, Siemens Healthineers, and Philips Healthcare dominate with comprehensive imaging portfolios and strong R&D capabilities. These companies focus on innovation, integrating AI, radiomics, and advanced software to improve diagnostic precision. Mid-tier players such as Canon Medical and Fujifilm compete through niche technologies and strategic partnerships. Startups and emerging firms are gaining ground by offering AI-driven imaging solutions tailored for oncology.

The market is highly competitive, with players investing in FDA approvals, collaborations with cancer research institutions, and global expansion. Technological advancements, especially in hybrid imaging and molecular diagnostics, are reshaping market dynamics. Pricing strategies, service offerings, and post-installation support also influence competitive positioning. The push toward personalized medicine and early cancer detection continues to drive innovation and rivalry among key stakeholders.

Recent Developments:

In December 2024, Guardant Health, Inc. announced a partnership with Boehringer Ingelheim to secure regulatory approval and advance the commercialization of the Guardant360 CDx liquid biopsy. This collaboration focuses on utilizing the liquid biopsy as a companion diagnostic (CDx) for zongertinib, a novel covalent tyrosine kinase inhibitor (TKI) that selectively targets HER2 while minimizing effects on the epidermal growth factor receptor (EGFR) in non-small cell lung cancer (NSCLC).

In November 2024, Danaher Corporation revealed plans to establish two new Centers of Innovation in Diagnostics to drive advancements in precision medicine. The first center, based in Newcastle, UK, is set to open in July and will serve as a collaborative research hub with leading pharmaceutical and academic partners. Operated by Leica Biosystems, a Danaher subsidiary, this facility will become Danaher's first CLIA CAP-certified laboratory.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CANCER IMAGING SYSTEM MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• GE HealthCare
• Siemens Healthineers
• Philips Healthcare
• Canon Medical Systems
• Fujifilm Holdings
• Hologic Inc.
• Bracco Imaging
• Carestream Health
• Esaote SpA
• Shimadzu Corporation
• Samsung Medison
• United Imaging Healthcare
• PerkinElmer Inc.
• Agfa-Gevaert Group
• Konica Minolta Healthcare
• Mindray Medical International
• Neusoft Medical Systems
• ViewRay Inc.
• Hyperfine Inc.
• Median Technologies

GLOBAL CANCER IMAGING SYSTEM MARKET, BY IMAGING MODALITY- MARKET ANALYSIS, 2019 - 2032

• Magnetic Resonance Imaging (MRI)
• Computed Tomography (CT)
• Positron Emission Tomography (PET)
• Ultrasound
• Mammography
• Others

GLOBAL CANCER IMAGING SYSTEM MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Prostate Cancer
• Liver Cancer
• Others

GLOBAL CANCER IMAGING SYSTEM MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

• Hospitals
• Diagnostic Imaging Centers
• Specialty Clinics
• Academic and Research Institutes

GLOBAL CANCER IMAGING SYSTEM MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Sweden
• Russia
• Poland
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Thailand
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Cancer Imaging System Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Cancer Imaging System Market Snippet by Imaging Modality
  • 2.1.2. Cancer Imaging System Market Snippet by Application
  • 2.1.3. Cancer Imaging System Market Snippet by End-user
  • 2.1.4. Cancer Imaging System Market Snippet by Country
  • 2.1.5. Cancer Imaging System Market Snippet by Region
• 2.2. Competitive Insights

3. Cancer Imaging System Key Market Trends

• 3.1. Cancer Imaging System Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Cancer Imaging System Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Cancer Imaging System Market Opportunities
• 3.4. Cancer Imaging System Market Future Trends

4. Cancer Imaging System Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Cancer Imaging System Market: Impact of Escalating Geopolitical Tensions

• 5.1. Impact of COVID-19 Pandemic
• 5.2. Impact of Russia-Ukraine War
• 5.3. Impact of Middle East Conflicts

6. Cancer Imaging System Market Landscape

• 6.1. Cancer Imaging System Market Share Analysis, 2024
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Cancer Imaging System Market - By Imaging Modality

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Imaging Modality, 2024 & 2032 (%)
  • 7.1.2. Magnetic Resonance Imaging (MRI)
  • 7.1.3. Computed Tomography (CT)
  • 7.1.4. Positron Emission Tomography (PET)
  • 7.1.5. Ultrasound
  • 7.1.6. Mammography
  • 7.1.7. Others

8. Cancer Imaging System Market - By Application

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
  • 8.1.2. Breast Cancer
  • 8.1.3. Lung Cancer
  • 8.1.4. Colorectal Cancer
  • 8.1.5. Prostate Cancer
  • 8.1.6. Liver Cancer
  • 8.1.7. Others

9. Cancer Imaging System Market - By End-user

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
  • 9.1.2. Hospitals
  • 9.1.3. Diagnostic Imaging Centers
  • 9.1.4. Specialty Clinics
  • 9.1.5. Academic and Research Institutes

10. Cancer Imaging System Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. Cancer Imaging System Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. Cancer Imaging System Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.8. UK
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.8.3. UK Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8.5. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.9. France
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.9.3. France Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.10. Italy
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.10.3. Italy Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.11. Spain
    • 10.3.11.1. Overview
    • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.11.3. Spain Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11.5. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.12. The Netherlands
    • 10.3.12.1. Overview
    • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.12.3. The Netherlands Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12.5. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.13. Sweden
    • 10.3.13.1. Overview
    • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.13.3. Sweden Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13.5. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.14. Russia
    • 10.3.14.1. Overview
    • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.14.3. Russia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14.5. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.15. Poland
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.15.3. Poland Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15.5. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.16. Rest of Europe
    • 10.3.16.1. Overview
    • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. Cancer Imaging System Key Manufacturers in Asia Pacific
  • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.4.4. APAC Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
  • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.6. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.7. China
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.7.3. China Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.8. India
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.8.3. India Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.9.3. Japan Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.10.3. South Korea Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.12. Indonesia
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.12.3. Indonesia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.13. Thailand
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.13.3. Thailand Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.15. Rest of APAC
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.15.3. Rest of APAC Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
• 10.5. Latin America (LATAM)
  • 10.5.1. Overview
  • 10.5.2. Cancer Imaging System Key Manufacturers in Latin America
  • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.5.4. LATAM Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
  • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5.6. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
• 10.6. Middle East and Africa (MEA)
  • 10.6.1. Overview
  • 10.6.2. Cancer Imaging System Key Manufacturers in Middle East and Africa
  • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.6.4. MEA Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
  • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.6. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6.8. UAE
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.8.3. UAE Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8.5. UAE Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6.13. Rest of MEA
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.13.3. Rest of MEA Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Cancer Imaging System Industry

• 11.1. Competitive Dashboard
  • 11.1.1. Competitive Benchmarking
  • 11.1.2. Competitive Positioning
• 11.2. Company Profiles
  • 11.2.1. GE HealthCare
  • 11.2.2. Siemens Healthineers
  • 11.2.3. Philips Healthcare
  • 11.2.4. Canon Medical Systems
  • 11.2.5. Fujifilm Holdings
  • 11.2.6. Hologic Inc.
  • 11.2.7. Bracco Imaging
  • 11.2.8. Carestream Health
  • 11.2.9. Esaote SpA
  • 11.2.10. Shimadzu Corporation
  • 11.2.11. Samsung Medison
  • 11.2.12. United Imaging Healthcare
  • 11.2.13. PerkinElmer Inc.
  • 11.2.14. Agfa-Gevaert Group
  • 11.2.15. Konica Minolta Healthcare
  • 11.2.16. Mindray Medical International
  • 11.2.17. Neusoft Medical Systems
  • 11.2.18. ViewRay Inc.
  • 11.2.19. Hyperfine Inc.
  • 11.2.20. Median Technologies

12. 360 Degree Analyst View

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us